USOR 20363_AZ_SERENA-4 | Maryland Oncology Hematology USOR 20363_AZ_SERENA-4 – Maryland Oncology Hematology

USOR 20363_AZ_SERENA-4

Trial Information

SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrozole plus Palbociclib for the Treatment of Patients with Estrogen Receptor



Sponsor: AstraZeneca

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Breast Cancer

Investigator

Ackerman, Courtney

Sponsor

AstraZeneca
« Clinical Trails Main

Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology